Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000551247 | SCV000648382 | likely benign | Dilated cardiomyopathy 1DD | 2025-01-13 | criteria provided, single submitter | clinical testing | |
Center for Advanced Laboratory Medicine, |
RCV000852633 | SCV000995338 | likely benign | Heart failure | 2019-03-18 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000551247 | SCV002049415 | uncertain significance | Dilated cardiomyopathy 1DD | 2020-12-21 | criteria provided, single submitter | clinical testing | The RBM20 c.3169C>T; p.Arg1057Trp variant (rs199830512), to our knowledge, is not reported in the medical literature but is reported in ClinVar (Variation ID: 470608). This variant is found in the general population with an overall allele frequency of 0.01% (17/187988 alleles) in the Genome Aggregation Database. The arginine at codon 1057 is moderately conserved, and computational analyses are uncertain whether this variant is neutral or deleterious (REVEL: 0.189). Due to limited information, the clinical significance of the p.Arg1057Trp variant is uncertain at this time. |
Mayo Clinic Laboratories, |
RCV002261114 | SCV002541108 | uncertain significance | not provided | 2021-10-13 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002324011 | SCV002607721 | uncertain significance | Cardiovascular phenotype | 2024-06-07 | criteria provided, single submitter | clinical testing | The p.R1057W variant (also known as c.3169C>T), located in coding exon 11 of the RBM20 gene, results from a C to T substitution at nucleotide position 3169. The arginine at codon 1057 is replaced by tryptophan, an amino acid with dissimilar properties. This variant has been detected in an individual with dilated cardiomyopathy (Robles-Mezcua A et al. Eur J Med Genet. 2021 Sep;64(9):104278). This amino acid position is poorly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Based on the available evidence, the clinical significance of this variant remains unclear. |
Gene |
RCV002261114 | SCV005080509 | uncertain significance | not provided | 2024-04-18 | criteria provided, single submitter | clinical testing | In silico analysis indicates that this missense variant does not alter protein structure/function; Reported in an individual with DCM and in an individual with drug-induced arrhythmia in published literature (PMID: 34174465, 31376648); This variant is associated with the following publications: (PMID: 34174465, 31376648) |